GILEAD SCIENCES, INC. — Director's Dealing 2016

Feb 3, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2016-02-01

Reporting Person: MARTIN JOHN C (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-01	Common Stock	M	100000	$16.395	Acquired	4048066	Direct
2016-02-01	Common Stock	S	43627	$82.9795	Disposed	4004439	Direct
2016-02-01	Common Stock	S	55973	$83.7652	Disposed	3948466	Direct
2016-02-01	Common Stock	S	400	$84.3475	Disposed	3948066	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-01	Non-Qualified Stock option (right to buy)	$16.395	M	100000	Disposed	2017-01-22	Common Stock (100000)	Direct
2016-02-01	Non-Qualified Stock option (right to buy)	$84.05	A	128630	Acquired	2026-02-01	Common Stock (128630)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F3: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.

F4: Sale prices reported for the transactions reported here range from $82.31 to $83.31. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F5: Sale prices reported for the transactions reported here range from $83.32 to $84.30. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F6: Sale prices reported for the transactions reported here range from $84.33 to $84.38. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.